These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34941102)

  • 21. The pharmacological management of hairy cell leukemia.
    Ramos Perez J; Ravandi-Kashani F
    Expert Opin Pharmacother; 2020 Aug; 21(11):1337-1344. PubMed ID: 32378970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variant hairy cell leukemia following papillary urothelial neoplasm of bladder.
    Beyan C; Kaptan K
    J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S27-8. PubMed ID: 24717996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological spectrum of hairy-cell leukemia: A single-center study with brief review of Indian literature.
    Gupta R; Yadav S; Mittal N; Rahman K; Sharma A; Gupta A; Nityan S
    J Cancer Res Ther; 2020; 16(1):120-126. PubMed ID: 32362621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunophenotyping of leukemic cells in the diagnosis of hairy cell leukemia].
    Gotić M; Kraguljac N; RolovićZ ; Radosević N; Bosković D
    Srp Arh Celok Lek; 2000; 128(5-6):157-64. PubMed ID: 11089415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
    Yang MH; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell Leukemia.
    Chihara D; Arons E; Stetler-Stevenson M; Yuan CM; Wang HW; Zhou H; Raffeld M; Xi L; Steinberg SM; Feurtado J; James L; Wilson W; Braylan RC; Calvo KR; Maric I; Dulau-Florea A; Kreitman RJ
    J Clin Oncol; 2020 May; 38(14):1527-1538. PubMed ID: 32109194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.
    Shao H; Calvo KR; Grönborg M; Tembhare PR; Kreitman RJ; Stetler-Stevenson M; Yuan CM
    Leuk Res; 2013 Apr; 37(4):401-409. PubMed ID: 23347903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant.
    Wang Y; Wang T; Yu Y; Wang Q; Yan Y; Li R; Sun Q; Xiong W; Lyu R; Yu Z; Liu W; Sui W; Huang W; Wang H; Li C; Wang J; Zou D; An G; Wang J; Qiu L; Yi S
    Ann Hematol; 2022 Jun; 101(6):1201-1210. PubMed ID: 35437610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues.
    Kreitman RJ; Arons E
    Blood Rev; 2022 Jan; 51():100888. PubMed ID: 34535326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous manifestation of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).
    Sokol L; Agosti SJ
    Am J Hematol; 2004 Feb; 75(2):107-9. PubMed ID: 14755378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD5 positive hairy cell leukemia: A rare case report with brief review of literature.
    Jain D; Dorwal P; Gajendra S; Pande A; Mehra S; Sachdev R
    Cytometry B Clin Cytom; 2016 Sep; 90(5):467-72. PubMed ID: 27129891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. My treatment approach to hairy cell leukemia.
    Naik RR; Saven A
    Mayo Clin Proc; 2012 Jan; 87(1):67-76. PubMed ID: 22212971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of hairy cell leukemia by flow cytometry.
    Stetler-Stevenson M; Tembhare PR
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2():11-3. PubMed ID: 21504292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment Outcomes Of Patients With Hairy Cell Leukaemia; A 16-Year Experience At A Tertiary Care Center In Pakistan.
    Yousaf M; Khan MA; Iftikhar R; Chaudary QU; Shahbaz N; Ahmad U; Javed H
    J Ayub Med Coll Abbottabad; 2022; 34(4):797-801. PubMed ID: 36566402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hairy cell leukemia complicated by bone marrow necrosis following cladribine administration].
    Terao T; Yuda J; Yamauchi N; Miyamoto K; Minami M; Kojima M; Sugano M; Kuwata T; Minami Y
    Rinsho Ketsueki; 2019; 60(6):559-564. PubMed ID: 31281144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia.
    Ravandi F; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Koller C; Challagundla P; York S; Brandt M; Luthra R; Burger J; Thomas D; Keating M; Kantarjian H
    Blood; 2011 Oct; 118(14):3818-23. PubMed ID: 21821712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hairy cell leukemia: an update.
    Goodman GR; Bethel KJ; Saven A
    Curr Opin Hematol; 2003 Jul; 10(4):258-66. PubMed ID: 12799530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First-Line Treatment of Hairy Cell Leukemia with Cladribine Followed by Rituximab Consolidation Significantly Improves Leukemia-Free Survival.
    Amhaz G; Ibrahim A; Usta U; El Cheikh J; Bazarbachi A; Abou Dalle I
    Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):564-566. PubMed ID: 33994319
    [No Abstract]   [Full Text] [Related]  

  • 39. Cladribine in hairy cell leukemia.
    Belani R; Saven A
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case report.
    Buckstein R; Patel H; Chesney A; Reis M; Imrie K
    Hematology; 2006 Aug; 11(4):267-70. PubMed ID: 17178666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.